Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDR2 | Q16832 | 2/20 | 0.64 |
| ▸ | RAF1 | P04049 | 6/20 | 0.51 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.42 |
| ▸ | PRMT6 | Q96LA8 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15574181 | 0.89 | DDR2 (0.80) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL169159 | 0.89 | DDR2 (0.71) | DDR2RAF1CARM1PRMT6 | |
| SCHEMBL15573229 | 0.89 | DDR2 (0.52) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL16990677 | 0.88 | DDR2 (0.74) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL16990737 | 0.87 | DDR2 (0.73) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL16990592 | 0.87 | DDR2 (0.68) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL15573113 | 0.87 | DDR2 (0.61) | DDR2RAF1SMN1; SMN2HTTALDH1A1 | |
| SCHEMBL16990594 | 0.86 | DDR2 (0.60) | DDR2RAF1CARM1PRMT6 | |
| SCHEMBL15574741 | 0.86 | DDR2 (0.62) | DDR2RAF1CARM1PRMT6SMN1; SMN2 | |
| SCHEMBL16990582 | 0.85 | RAF1 (0.51) | DDR2RAF1CARM1PRMT6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150225369-A1 | DDR2 INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | MERCK PATENT GMBH (DE) | 2015-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225369-A1 | DDR2 INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | DDR2, DDR1, DDRGK1 | DDR2 1/4885RAF1 3072/4885CARM1 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.